Biotech SF
San Francisco Bay Area biotech stories.
Wednesday, July 20, 2011
SuperGen closes deal with Astex; CEO wins $410K bonus
Overcoming shareholder criticism, SuperGen Inc. closed Wednesday on its acquisition of Astex Therapeutics Ltd. that won its CEO a $410,000 bonus and its new president a $449,000 salary.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment